Sort   by:  
 Page size 
ProteomicsLC-MSMS of the MHC-I immunopeptidome of human melanoma
While immune checkpoint blockade (ICB) therapy has significantly improved the outcome of metastatic melanoma and non-small cell lung cancer (NSCLC), most patients do not derive long-term benefits. Previous studies suggest that treatment failure is partly due to insufficient immune recognition of tum...
ORGANISM(S): Homo sapiens (Human) 
2025-02-19 | PXD043059 | Pride
Lc-msms Melanoma Immunopeptidome Mhc class i 
ProteomicsLC-MSMS of the MHC-I immunopeptidome of human NSCLC samples
While immune checkpoint blockade (ICB) therapy has significantly improved the outcome of metastatic melanoma and non-small cell lung cancer (NSCLC), most patients do not derive long-term benefits. Previous studies suggest that treatment failure is partly due to insufficient immune recognition of tum...
ORGANISM(S): Homo sapiens (Human) 
2025-02-19 | PXD043057 | Pride
Non-small cell lung cancer Lc-msms Immunopeptidome Mhc class i 
Sort   by:  
 Page size